10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

________________________________________________________________________

FORM 10-Q/A

(Amendment No. 1)

________________________________________________________________________

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from               to               

Commission file number 001-36371

________________________________________________________________________

Everyday Health, Inc.

(Exact name of registrant as specified in its charter)

________________________________________________________________________

Delaware	80-0036062
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
345 Hudson Street, 16th Floor New York, NY	10014
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (646) 728-9500

(former name, former address and former fiscal year, if changed since last report) 

________________________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  o    No  x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x  (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x

The number of shares outstanding of the Registrant’s common stock, $0.01 par value per share, on May 9, 2014, was 30,091,942.

Explanatory Note

This Amendment No. 1 (the “Amendment”) to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, originally filed with the Securities and Exchange Commission on May 13, 2014 (the “Form 10-Q”), is being filed solely to furnish Exhibit 101 to the Form 10-Q, which provides items formatted in XBRL (eXtensible Business Reporting Language). As permitted by Rule 405(a)(2)(ii) of Regulation S-T, this Amendment is being filed within 30 days of the original filing date of the Form 10-Q.

No other changes have been made to the Form 10-Q except for the furnishing of the exhibit described above. The Amendment does not reflect subsequent events occurring after the filing date of the Form 10-Q or modify or update any disclosures set forth in the Form 10-Q.

Item 6.       Exhibits.

Exhibit Number	Description of Document
3.1(1)	Amended and Restated Certificate of Incorporation.
3.2(2)	Amended and Restated Bylaws.
10.1(3)	2014 Equity Incentive Plan and related documents.
10.2(4)	Everyday Health, Inc. 2014 Employee Stock Purchase Plan.
10.3(5)	Credit Agreement with Silicon Valley Bank, SunTrust Bank and Stifel Bank & Trust, dated as of March 6, 2014.
31.1(6)	Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2(6)	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1(6)	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2(6)	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS(7)	XBRL Instance Document
101.SCH(7)	XBRL Taxonomy Extension Schema
101.CAL(7)	XBRL Taxonomy Extension Calculation Linkbase
101.DEF(7)	XBRL Taxonomy Extension Definition Linkbase
101.LAB(7)	XBRL Taxonomy Extension Label Linkbase
101.PRE(7)	XBRL Taxonomy Extension Presentation Linkbase

___________________

(1) Incorporated herein by reference to Exhibit 3.1 to the Registrant’s Form 8-K (File No. 001-36371) filed on April 7, 2014.

(2) Incorporated herein by reference to Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed on February 24, 2014, as amended.

(3) Incorporated herein by reference to Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed on February 24, 2014, as amended.

(4) Incorporated herein by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed on February 24, 2014, as amended.

(5) Incorporated herein by reference to Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed on February 24, 2014, as amended.

(6) Previously filed as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed on May 13, 2014.

(7) Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 furnished hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are not deemed filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EVERYDAY HEALTH, INC.
By:	/s/ Benjamin Wolin
	Benjamin Wolin Chief Executive Officer and Director (Principal Executive Officer)
By:	/s/ Brian Cooper
	Brian Cooper Executive Vice President & Chief Financial Officer (Principal Financial and Accounting Officer)

Date: June 10, 2014

XML

Stock-Based Compensation (Details) - Schedule of weighted-average assumptions (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Schedule of weighted-average assumptions [Abstract]
Volatility	49.77%	50.26%
Expected life (years)	6 years 3 months	6 years 3 months
Risk-free interest rate	1.92%	1.32%
Dividend yield (in Dollars per share)	$ 0	$ 0

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 82,153		$ 82,153
Finite-Lived Intangible Assets, Net	9,190		9,735
Amortization of Intangible Assets	$ 545	$ 1,015

XML

Subsequent Events (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended				0 Months Ended			3 Months Ended			0 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013	Apr. 30, 2014 IPO [Member] Automatic Net Exercise of a Warrant [Member]	Apr. 30, 2014 IPO [Member] Ratchet Provision [Member] Series G Preferred Stock [Member]	Apr. 30, 2014 IPO [Member]	Apr. 02, 2014 IPO [Member]	Mar. 31, 2014 Ratchet Provision [Member]	Mar. 31, 2014 Series G Preferred Stock [Member]	Dec. 31, 2013 Series G Preferred Stock [Member]	Apr. 07, 2014 Revolving Credit Facility [Member]
Subsequent Events (Details) [Line Items]
Proceeds from Issuance of Common Stock (in Dollars)						$ 72,019
Expense Related to Distribution or Servicing and Underwriting Fees (in Dollars)						8,325
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478	149,839		5,676,414
Shares Issued, Price Per Share (in Dollars per share)	$ 14.00					$ 14.00				$ 9.00
Conversion of Stock, Shares Issued						18,457,235
Conversion of Stock, Shares Converted	18,457,235				577,055
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686				262,686
Convertible Preferred Stock, Shares Reserved for Future Issuance						222,977
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock						148,650		577,055
Additional Paid in Capital, Preferred Stock (in Dollars)						1,140
Common Stock, Shares Authorized	45,000,000		45,000,000				90,000,000
Preferred Stock, Shares Authorized	27,204,144		27,204,144				10,000,000		3,333,333
Line of Credit Facility, Increase (Decrease), Net (in Dollars)											32,300
Line of Credit Facility, Current Borrowing Capacity (in Dollars)											$ 35,000

XML

Discontinued Operations

3 Months Ended

Mar. 31, 2014

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

3. Discontinued Operations

In November 2013, the Company completed the sale of its Doctor Solutions business, which provided online directories and other marketing services to healthcare professionals. The sales price was $1,000. The sale represented a disposal of a component of an entity whose operations and cash flows were eliminated from the Company’s ongoing business after the sale. As such, the operating results have been reported as discontinued operations in the consolidated statements of operations for the three months ended March 31, 2013. As the sale was completed during 2013, there were no results from discontinued operations to report for the three months ended March 31, 2014. Revenues and losses from discontinued operations before tax were $2,202 and $1,745, respectively, for the three months ended March 31, 2013. No benefit for income taxes was provided as the Company recorded a full valuation allowance against the net operating losses (“NOLs”) generated by the discontinued operations.

XML

Common Stock and Redeemable Convertible Preferred Stock (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		3 Months Ended																3 Months Ended		3 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Mar. 31, 2014 Effect of 1-for-1.5 stock split [Member] Series G Preferred Stock [Member]	Mar. 31, 2014 Ratchet Provision [Member]	Mar. 31, 2014 Ratchet Provision Deemed Dividend [Member] Series G Preferred Stock [Member]	Apr. 02, 2014 Ratchet Provision Deemed Dividend [Member] Series G Preferred Stock [Member]	Mar. 31, 2014 Series A Preferred Stock [Member]	Dec. 31, 2013 Series A Preferred Stock [Member]	Mar. 31, 2014 Series B Preferred Stock [Member]	Dec. 31, 2013 Series B Preferred Stock [Member]	Mar. 31, 2014 Series C Preferred Stock [Member]	Dec. 31, 2013 Series C Preferred Stock [Member]	Mar. 31, 2014 Series D Preferred Stock [Member]	Dec. 31, 2013 Series D Preferred Stock [Member]	Mar. 31, 2014 Series E Preferred Stock [Member]	Dec. 31, 2013 Series E Preferred Stock [Member]	Mar. 31, 2014 Series F Preferred Stock [Member]	Dec. 31, 2013 Series F Preferred Stock [Member]	Mar. 31, 2014 Series G Preferred Stock [Member]	Dec. 31, 2013 Series G Preferred Stock [Member]	Mar. 31, 2014 Series A, B, C, D, E, F [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	On March 12, 2014, the Company's Board of Directors and stockholders approved an amendment to the Company's amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company's issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company's consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.
Shares Issued, Price Per Share	$ 14.00							$ 0.50		$ 1.77		$ 3.27		$ 6.87		$ 7.98		$ 7.61		$ 9.00
Conversion Price IPO Adjustment Threshold																			$ 11.88
Temporary Equity, Shares Outstanding (in Shares)	26,820,270						3,450,000		2,547,252		1,833,633		3,934,855		8,930,966		2,951,128		3,172,436		23,647,834
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																			2,692,012		15,765,223
Conversion Price IPO Adjustment Increase			$ 17.82
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock (in Shares)				577,055
Dividends (in Dollars)					$ 8,079	$ 8,079
Class of Warrant or Right, Outstanding (in Shares)	100,000	222,977
Investment Warrants, Exercise Price	$ 0.015
Deferred Tax Liabilities, Deferred Expense, Deferred Financing Costs (in Dollars)	$ 1,131

XML

Long-Term Debt (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended			3 Months Ended		0 Months Ended	3 Months Ended				3 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013	Mar. 31, 2014 Series F Preferred Stock [Member] Former credit facility [Member]	Mar. 31, 2014 Series C Preferred Stock [Member] Former credit facility [Member]	Apr. 02, 2014 IPO [Member]	Mar. 31, 2014 Revolving Credit Facility [Member]	Dec. 31, 2013 Revolving Credit Facility [Member]	Mar. 31, 2014 Term Loan Facility [Member]	Dec. 31, 2013 Term Loan Facility [Member]	Mar. 31, 2014 Former credit facility [Member]	Mar. 31, 2014 Minimum [Member]	Mar. 31, 2014 Maximum [Member]
Long-Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity							$ 35,000		$ 40,000
Line of Credit Facility, Interest Rate Description	The interest rate on the new credit facility (hereinafter the "Credit Facility") is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company's consolidated leverage ratio
Line of Credit Facility, Interest Rate at Period End	4.23%											2.75%	4.00%
Line of Credit Facility, Amount Outstanding							32,300		40,000
Payments of Financing Costs	(2,227)						1,211				1,016
Write off of Deferred Debt Issuance Cost											2,845
Line of Credit Facility, Borrowing Capacity, Description	Under the former senior credit facility, as amended, with a bank, the Company maintained (i) an accounts receivable-backed revolver, with a maximum borrowing limit equal to the lesser of $30,000 and 80% of eligible accounts receivable, and (ii) an $8,500 term loan.
Debtor-in-Possession Financing, Borrowings Outstanding			40,000					30,000		1,333
Debtor-in-Possession Financing, Interest Rate on Borrowings Outstanding			14.00%					5.25%		6.50%
Shares upon warrant exercises (in Shares)				112,959	110,018						592,501
Investment Warrants, Exercise Price (in Dollars per share)	$ 0.015			$ 7.61	$ 3.27						$ 0.015
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)		18,457,235				222,977
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock (in Shares)						148,650
Additional Paid in Capital	$ 37,326	$ 1,140	$ 33,726

XML

Common Stock and Redeemable Convertible Preferred Stock (Details) - Schedule of redeemable convertible preferred stock (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	27,204,144	27,204,144
Redeemable convertible preferred stock	26,820,270
Redeemable convertible preferred stock	$ 158,766	$ 158,766
Redeemable convertible preferred stock	114,627
Series A Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	3,450,000
Redeemable convertible preferred stock	3,450,000
Redeemable convertible preferred stock	1,053
Redeemable convertible preferred stock	1,725
Series B Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	2,547,252
Redeemable convertible preferred stock	2,547,252
Redeemable convertible preferred stock	4,413
Redeemable convertible preferred stock	4,500
Series C Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	1,943,651
Redeemable convertible preferred stock	1,833,633
Redeemable convertible preferred stock	5,882
Redeemable convertible preferred stock	6,000
Series D Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	3,934,855
Redeemable convertible preferred stock	3,934,855
Redeemable convertible preferred stock	25,354
Redeemable convertible preferred stock	27,027
Series E Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	8,930,966
Redeemable convertible preferred stock	8,930,966
Redeemable convertible preferred stock	71,250
Redeemable convertible preferred stock	15,789
Series F Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	3,064,087
Redeemable convertible preferred stock	2,951,128
Redeemable convertible preferred stock	22,468
Redeemable convertible preferred stock	22,468
Series G Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock	3,333,333
Redeemable convertible preferred stock	3,172,436
Redeemable convertible preferred stock	28,346
Redeemable convertible preferred stock	$ 37,118

XML

Stock-Based Compensation (Details) (USD $)	3 Months Ended			3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014 2014 Plan [Member]	Mar. 31, 2014 Employee Stock [Member]	Mar. 27, 2014 Employee Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock, aggregate shares issued, description				The aggregate number of shares of the Company's common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting).
Common stock, number of shares reserved for issuance, description				In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company's common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.	The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b).
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)				593,574
Proceeds from Stock Options Exercised	$ 1,172,000	$ 3,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	910,000	12,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$ 7.56
Allocated Share-based Compensation Expense		480,000
Other Adjustments to Income, Discontinued Operations		28
Share-based Compensation	1,069,000	452,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	11,755,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 357 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 953,000	$ 1,402,000
Common Stock, Shares Authorized (in Shares)	45,000,000		45,000,000			500,000
Common stock, purchase for participating employee price, description					Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase.
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.01		$ 0.01		$ 14.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares)					0.15

XML

Significant Accounting Policies

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

2. Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Interim Financial Statements

The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2013 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the three month periods ended March 31, 2013 and 2014. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s prospectus dated March 27, 2014, filed with the SEC on March 28, 2014 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the “Securities Act”).

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassifications

Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2014 presentation.

Initial Public Offering and Pro Forma Presentation

On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the “IPO-Related Transactions”): i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital. The unaudited pro forma March 31, 2014 consolidated balance sheet has been adjusted to reflect the above described IPO-Related Transactions.

The unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 has been adjusted to reflect, as of January 1, 2014, the completion of the Company’s IPO and related changes in stockholders’ equity as described above, and a deemed dividend on Series G redeemable convertible preferred stock of $8,079 (refer to Notes 6 and 8).

The Company believes that the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides material information to investors, as the historical reported amounts as of and for the three months ended March 31, 2014 were significantly impacted by the closing of the IPO in April 2014. Therefore, the disclosure of the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides measures of equity, net loss and net loss per common share that are comparable to what will be reported by the Company in its consolidated financial statements for the periods subsequent to and including April 2014.

Revenue Recognition and Deferred Revenue

The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.

Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.

Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Revenues

Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.

Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Expense

During the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016 in connection with the refinancing of its credit facilities, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations. There were no similar write-offs or charges for the three months ended March 31, 2013.

Comprehensive Income

The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments

Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.

The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended 2013 and 2014.

Segment Information

The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.

Recent Accounting Standards

In April 2014, the Financial Accounting Standards Board issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This will be effective for the first annual reporting period beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact, if any, the guidance with have upon adoption.

XML

Stock-Based Compensation (Details) - Schedule of stock option activity (USD $) In Thousands, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended
	Dec. 31, 2013	Mar. 31, 2014	Apr. 02, 2014
Schedule of stock option activity [Abstract]
Outstanding	5,457,791	6,673,806
Outstanding	$ 7.61	$ 9.14
Outstanding	6 years 197 days	7 years 43 days
Outstanding	$ 20,396	$ 33,737
Granted		1,472,101
Granted		$ 14.53
Exercised		(113,580)	(262,686)
Exercised		$ 4.26
Cancelled		(142,506)
Cancelled		$ 8.22
Exercisable at March 31, 2014		3,965,974
Exercisable at March 31, 2014		$ 7.33
Exercisable at March 31, 2014		5 years 215 days
Exercisable at March 31, 2014		$ 26,396

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 14,770	$ 16,242
Accounts receivable, net of allowance for doubtful accounts of $530, $642 and $642 as of December 31, 2013, March 31, 2014 and pro forma March 31, 2014, respectively	38,223	49,373
Deferred tax asset	133	133
Prepaid expenses and other current assets	9,627	7,822
Total current assets	62,753	73,570
Property and equipment, net	21,751	21,095
Goodwill	82,153	82,153
Intangible assets, net	9,190	9,735
Other assets	4,910	5,729
Total assets	180,757	192,282
Current liabilities:
Accounts payable	6,754	8,459
Accrued expenses	18,094	25,919
Deferred revenue	7,376	6,808
Current portion of long-term debt	1,500	1,333
Other current liabilities	929	830
Total current liabilities	34,653	43,349
Long-term debt	70,800	70,000
Deferred tax liabilities	5,440	5,199
Other long-term liabilities	5,224	4,937
Redeemable convertible preferred stock (Series A-G), net of expenses, $0.01 par value: 27,204,144 shares authorized at December 31, 2013 and March 31, 2014; 26,820,270 shares issued and outstanding at December 31, 2013 and March 31, 2014 (aggregate liquidation value of $114,627 at March 31, 2014); no shares issued and outstanding at March 31, 2014, pro forma	158,766	158,766
Stockholders’ equity (deficit):
Common stock, $0.01 par value: 45,000,000 shares authorized at December 31, 2013 and March 31, 2014; 5,366,478 and 5,545,768 shares issued and outstanding at December 31, 2013 and March 31, 2014, respectively; 30,091,942 shares issued and outstanding at March 31, 2014, pro forma	56	54
Treasury stock	(55)	(55)
Additional paid-in capital	37,326	33,726
Accumulated deficit	(131,453)	(123,694)
Total stockholders’ equity (deficit)	(94,126)	(89,969)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	180,757	192,282
Pro Forma [Member]
Current assets:
Cash and cash equivalents	89,551
Accounts receivable, net of allowance for doubtful accounts of $530, $642 and $642 as of December 31, 2013, March 31, 2014 and pro forma March 31, 2014, respectively	38,223
Deferred tax asset	133
Prepaid expenses and other current assets	6,865
Total current assets	134,772
Property and equipment, net	21,751
Goodwill	82,153
Intangible assets, net	9,190
Other assets	4,910
Total assets	252,776
Current liabilities:
Accounts payable	6,754
Accrued expenses	18,094
Deferred revenue	7,376
Current portion of long-term debt	1,500
Other current liabilities	929
Total current liabilities	34,653
Long-term debt	70,800
Deferred tax liabilities	5,440
Other long-term liabilities	4,084
Stockholders’ equity (deficit):
Common stock, $0.01 par value: 45,000,000 shares authorized at December 31, 2013 and March 31, 2014; 5,366,478 and 5,545,768 shares issued and outstanding at December 31, 2013 and March 31, 2014, respectively; 30,091,942 shares issued and outstanding at March 31, 2014, pro forma	301
Treasury stock	(55)
Additional paid-in capital	277,085
Accumulated deficit	(139,532)
Total stockholders’ equity (deficit)	137,799
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 252,776

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities
Net loss	$ (7,759)	$ (9,229)
Less loss from discontinued operations, net of tax		(1,745)
Loss from continuing operations	(7,759)	(7,484)
Adjustments to reconcile loss from continuing operations to net cash provided by operating activities:
Depreciation and amortization	3,558	3,920
Amortization of video and television costs		264
Provision for doubtful accounts	215	62
Stock-based compensation	1,069	452
Amortization and write-off of financing costs	4,169	421
Provision for deferred income taxes	241	241
Changes in operating assets and liabilities:
Accounts receivable	10,935	7,682
Prepaid expenses and other current assets	(2,645)	(420)
Additions to video and television costs		(389)
Accounts payable and accrued expenses	(8,610)	(2,398)
Deferred revenue	568	1,392
Other current liabilities	32	(352)
Other long-term liabilities	307	127
Net cash provided by operating activities from continuing operations	2,080	3,518
Net cash used in operating activities from discontinued operations		(1,745)
Net cash provided by operating activities	2,080	1,773
Cash flows from investing activities
Additions to property and equipment, net	(3,476)	(2,825)
Proceeds from sale of business	152
Payment for business purchased, net of cash acquired		(2,103)
Payment of security deposits and other assets	5	(782)
Net cash used in investing activities	(3,319)	(5,710)
Cash flows from financing activities
Proceeds from the exercise of stock options	1,172	3
Principal payments on capital lease obligations	(145)	(72)
Payments of credit facility financing costs	(2,227)
Payment for purchase of treasury stock		(55)
Net cash used in financing activities	(233)	(832)
Net decrease in cash and cash equivalents	(1,472)	(4,769)
Cash and cash equivalents, beginning of period	16,242	23,888
Cash and cash equivalents, end of period	14,770	19,119
Supplemental disclosure of cash flow information
Interest paid	2,262	1,670
Income taxes paid	16
Supplemental disclosure of non-cash investing and financing activities
Warrants issued in connection with website partner agreement	1,131
Capital lease obligations incurred	193	64
Equity Issued in Business Combination [Member]
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock for acquired business	919	907
Acquired Assets [Member]
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock for acquired assets		74
Revolving Credit Facility [Member]
Cash flows from financing activities
Repayments of principal	(30,000)
Borrowings	32,300
Payments of credit facility financing costs	1,211
Term Loan Facility [Member]
Cash flows from financing activities
Repayments of principal	(41,333)	(708)
Borrowings	$ 40,000

XML

Net Loss Per Share (Details) - Schedule of earnings per share (USD $)	3 Months Ended			3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Apr. 02, 2014	Mar. 31, 2014 Upon Initial Public Offering [Member]	Mar. 31, 2014 Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member]	Mar. 31, 2014 Ratchet Provision Deemed Dividend [Member] Series G Preferred Stock [Member]	Apr. 02, 2014 Ratchet Provision Deemed Dividend [Member] Series G Preferred Stock [Member]
Net Loss Per Share (Details) - Schedule of earnings per share [Line Items]
Historical net loss	$ (7,759,000)	$ (9,229,000)
Plus: deemed dividend on Series G Preferred Stock						(8,079,000)	(8,079,000)
Pro forma numerator for basic and diluted net loss per share attributable to common stockholders	(15,838,000)
Historical denominator for basic and diluted net loss per share—weighted average shares (in Shares)	5,403,846	4,925,306
Plus: conversion of redeemable convertible preferred stock to common stock (in Shares)	18,457,235
Plus: automatic net exercise of a warrant (in Shares)	149,839		148,650
Plus: shares issued				5,622,686	316,414
Pro forma denominator for basic and diluted net loss per share attributable to common shareholders	29,950,020
Pro forma basic and diluted net loss per share attributable to common shareholders	$ (0.53)

XML

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three months ended March 31, 2014
Numerator:
Historical net loss		$	(7,759	)
Plus: deemed dividend on Series G Preferred Stock			(8,079	)
Pro forma numerator for basic and diluted net loss per share attributable to common stockholders		$	(15,838	)
Denominator:
Historical denominator for basic and diluted net loss per share—weighted average shares			5,403,846
Plus: conversion of redeemable convertible preferred stock to common stock			18,457,235
Plus: automatic net exercise of a warrant			149,839
Plus: shares issued upon initial public offering, including shares exercised by certain selling shareholders			5,622,686
Plus: shares issued pursuant to the underwriters’ exercise of their over-allotment option			316,414
Pro forma denominator for basic and diluted net loss per share attributable to common shareholders			29,950,020
Pro forma basic and diluted net loss per share attributable to common shareholders		$	(0.53	)

XML

Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	0 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward	$ 108,000
Effective Income Tax Rate Reconciliation, Deduction, Amount	$ 3,317

XML

Discontinued Operations (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	3 Months Ended
	Nov. 30, 2013	Mar. 31, 2014 Revenues [Member]	Mar. 31, 2014 Losses [Member]
Discontinued Operations (Details) [Line Items]
Proceeds from Sales of Business, Affiliate and Productive Assets	$ 1,000
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax		$ 2,202	$ (1,745)

XML

Business

3 Months Ended

Mar. 31, 2014

Disclosure Text Block [Abstract]

Business Description and Basis of Presentation [Text Block]

1. Business

Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

XML

Consolidated Balance Sheets (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Allowance for doubtful accounts (in Dollars)	$ 642	$ 530
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	27,204,144	27,204,144
Preferred stock, shares issued	26,820,270	26,820,270
Preferred stock, shares outstanding	26,820,270	26,820,270
Preferred stock, aggregate liquidation value (in Dollars)	114,627
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued	5,545,768	5,366,478
Common stock, shares outstanding	5,545,768	5,366,478
Common stock, shares authorized	45,000,000	45,000,000
Pro Forma [Member]
Allowance for doubtful accounts (in Dollars)	$ 642
Preferred stock, par value (in Dollars per share)	$ 0.01
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Common stock, par value (in Dollars per share)	$ 0.01
Common stock, shares issued	30,091,942
Common stock, shares outstanding	30,091,942

XML

Subsequent Events

3 Months Ended

Mar. 31, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

11. Subsequent Events

On April 2, 2014, the Company closed its IPO. The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows: i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital.

On April 2, 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued, from time to time with terms to be set, by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.

On April 7, 2014, the Company paid down the $32,300 outstanding balance on its Revolver. As of the date of this filing, the full $35,000 line under the Revolver was available to be drawn (see Note 5).

XML

Document And Entity Information	3 Months Ended
	Mar. 31, 2014	May 09, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Everyday Health, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		30,091,942
Amendment Flag	false
Entity Central Index Key	0001358483
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1

XML

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation

Interim Financial Statement [Policy Text Block]

Interim Financial Statements

The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2013 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the three month periods ended March 31, 2013 and 2014. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s prospectus dated March 27, 2014, filed with the SEC on March 28, 2014 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the “Securities Act”).

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2014 presentation.

Sale of Stock, Description of Transaction

Initial Public Offering and Pro Forma PresentationOn April 2, 2014, the Company closed its initial public offering of common stock ("IPO"). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters' exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company's common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the "IPO-Related Transactions"): i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company's redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital. The unaudited pro forma March 31, 2014 consolidated balance sheet has been adjusted to reflect the above described IPO-Related Transactions.The unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 has been adjusted to reflect, as of January 1, 2014, the completion of the Company's IPO and related changes in stockholders' equity as described above, and a deemed dividend on Series G redeemable convertible preferred stock of $8,079 (refer to Notes 6 and 8).The Company believes that the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides material information to investors, as the historical reported amounts as of and for the three months ended March 31, 2014 were significantly impacted by the closing of the IPO in April 2014. Therefore, the disclosure of the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides measures of equity, net loss and net loss per common share that are comparable to what will be reported by the Company in its consolidated financial statements for the periods subsequent to and including April 2014.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition and Deferred Revenue

The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.

Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.

Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Sales, Policy [Policy Text Block]

Cost of Revenues

Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.

Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Income and Other Expense Disclosure [Text Block]

Other Expense

During the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016 in connection with the refinancing of its credit facilities, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations. There were no similar write-offs or charges for the three months ended March 31, 2013.

Comprehensive Income, Policy [Policy Text Block]

Comprehensive Income

The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.

The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended 2013 and 2014.

Segment Reporting, Policy [Policy Text Block]

Segment Information

The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Standards

In April 2014, the Financial Accounting Standards Board issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This will be effective for the first annual reporting period beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact, if any, the guidance with have upon adoption

XML

Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues:
Advertising and sponsorship revenues	$ 32,692,000	$ 25,380,000
Premium services revenues	4,813,000	5,124,000
Total revenues	37,505,000	30,504,000
Operating expenses:
Cost of revenues	11,421,000	9,835,000
Sales and marketing	10,970,000	9,061,000
Product development	10,196,000	10,344,000
General and administrative	6,411,000	6,355,000
Total operating expenses	38,998,000	35,595,000
Loss from operations	(1,493,000)	(5,091,000)
Interest expense, net	(1,863,000)	(2,129,000)
Other expense	(4,114,000)
Loss from continuing operations before provision for income taxes	(7,470,000)	(7,220,000)
Provision for income taxes	(289,000)	(264,000)
Loss from continuing operations	(7,759,000)	(7,484,000)
Loss from discontinued operations, net of tax		(1,745,000)
Net loss	(7,759,000)	(9,229,000)
Net loss from continuing operations per common share—basic and diluted (in Dollars per share)	$ (1.44)	$ (1.52)
Net loss from discontinued operations per common share—basic and diluted (in Dollars per share)		$ (0.35)
Net loss per common share—basic and diluted (in Dollars per share)	$ (1.44)	$ (1.87)
Weighted-average common shares outstanding—basic and diluted (in Shares)	5,403,846	4,925,306
Pro forma net loss per share attributable to common stockholders—basic and diluted	(0.53)
Pro forma weighted-average common shares outstanding—basic and diluted	$ 29,950,020

XML

Common Stock and Redeemable Convertible Preferred Stock

3 Months Ended

Mar. 31, 2014

Share-based Arrangements with Employees and Nonemployees [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

6. Common Stock and Redeemable Convertible Preferred Stock

On March 12, 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.

The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at each of December 31, 2013 and March 31, 2014:

	Shares				Stated value,
	Authorized		Issued and outstanding		net of expenses		Liquidation preference
Redeemable convertible preferred stock:
Series A		3,450,000		3,450,000	$	1,053	$	1,725
Series B		2,547,252		2,547,252		4,413		4,500
Series C		1,943,651		1,833,633		5,882		6,000
Series D		3,934,855		3,934,855		25,354		27,027
Series E		8,930,966		8,930,966		71,250		15,789
Series F		3,064,087		2,951,128		22,468		22,468
Series G		3,333,333		3,172,436		28,346		37,118
Total		27,204,144		26,820,270	$	158,766	$	114,627

Conversion of the Redeemable Convertible Preferred Stock

Each share of redeemable convertible preferred stock was convertible at the option of the holder, at any time, into such number of fully paid shares of the Company’s common stock equal to the applicable original issue price for such share of redeemable convertible preferred stock divided by the applicable conversion price for such share of redeemable convertible preferred stock then in effect. As of December 31, 2013, the original issue prices and the conversion prices for each series of redeemable convertible preferred stock were as follows: $0.50 for Series A, $1.77 for Series B, $3.27 for Series C, $6.87 for Series D, $7.98 for Series E, $7.61 for Series F and $9.00 for Series G. The conversion prices for each series of redeemable convertible preferred stock were subject to adjustment upon the occurrence of certain specified events, including stock dividends, stock splits, combinations or other similar recapitalizations, and issuance of capital stock at a price below the conversion price in effect for such series of redeemable convertible preferred stock. The conversion price for the Series G convertible preferred stock was also subject to further adjustment in the event of an IPO with a public offering price of less than $11.88 per share.

In connection with the March 14, 2014 1-for-1.5 reverse stock split, the conversion prices for each series of redeemable convertible preferred stock were subject to a 1-for-1.5 adjustment. As a result, upon the closing of the IPO, the 23,647,834 outstanding shares of Series A, Series B, Series C, Series D, Series E and Series F redeemable convertible preferred stock converted into a total of 15,765,223 shares of common stock. Based on this 1-for-1.5 adjustment, the conversion price for the IPO adjustment specific to the Series G shares increased from $11.88 per share to $17.82 per share. Based on the public offering price of $14.00 per share, the 3,172,436 outstanding shares of Series G convertible preferred stock converted into a total of 2,692,012 shares of common stock, including an additional 577,055 shares of common stock issued as a result of the specific Series G IPO adjustment feature or “ratchet provision.” The ratchet provision, which is treated as a deemed stock dividend for accounting purposes, was calculated as the difference between the number of shares of common stock each holder of Series G would receive upon the automatic conversion of the Series G shares and the number of shares contingently issuable just prior to the automatic conversion based on the initial conversion price multiplied by the IPO price of $14.00 per share, which represents the fair value of the common stock on the date of conversion. On April 2, 2014, the Company recorded a one-time $8,079 non-cash preferred stock deemed dividend related to the issuance of additional common shares resulting from the ratchet provision. Such non-cash preferred stock deemed dividend results in an increase to net loss to arrive at net loss attributable to common stockholders and, consequently, results in an adjustment to the Company’s computation of net loss per share attributable to common stockholders (refer to Note 8).

Issuance of Common Stock Warrant

During the three months ended March 31, 2014, the Company issued to one of its website partners a warrant to purchase 100,000 shares of common stock at $0.015 per share, in connection with the website partner agreeing to extend the advertising representation agreement by two years. The warrant was immediately exercisable and, accordingly, the Company calculated the fair value of the warrant using the Black-Scholes option pricing model and recorded $1,131 of deferred financing costs related to the issuance, which will be amortized to the Company’s operating results over the remaining life of the agreement.

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2014

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

5. Long-Term Debt

On March 6, 2014, the Company completed a refinancing of its credit facilities. Under the terms of the new credit facility agreement with a syndicated bank group, the Company maintains a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in March 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of March 2019. The interest rate on the new credit facility (hereinafter the “Credit Facility”) is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement. As of March 31, 2014, the interest rate on the Credit Facility was 4.23%. The Company drew the full $40,000 Term Loan and $32,300 on the Revolver at closing, and such amounts were outstanding as of March 31, 2014. See Note 11 for discussion of the Revolver pay-down in April 2014.

During the three months ended March 31, 2014, the Company incurred financing costs on the Credit Facility of $1,211, which have been deferred and are being amortized using the effective interest rate method through the final maturity of the Credit Facility, and incurred prepayment fees of $1,016 on the former credit facilities, which was charged to expense. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. In connection with the refinancing, during the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs of $2,845 related to the former credit facilities.

The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2014.

In connection with the refinancing discussed above, the Company repaid all outstanding borrowings under its former credit facilities, and such credit facilities were terminated.

Under the former senior credit facility, as amended, with a bank, the Company maintained (i) an accounts receivable-backed revolver, with a maximum borrowing limit equal to the lesser of $30,000 and 80% of eligible accounts receivable, and (ii) an $8,500 term loan. As of December 31, 2013, outstanding borrowings under the former revolver and former term loan amounted to $30,000 and $1,333, respectively, and as of such date, the interest rates on the former revolver and former term loan were 5.25% and 6.50%, respectively. The principal under the former revolver was due in full in September 2015. The maturity date of the former term loan was December 2014.

Under the Company’s former subordinated credit facility, as amended, the Company maintained a $40,000 term loan. As of December 31, 2013, outstanding borrowings under the former subordinated credit facility amounted to $40,000 and the interest rate on such facility was 14.0%. The maturity date of the former subordinated credit facility was October 2015 with respect to $35,000 and November 2016 with respect to $5,000.

The former senior credit facility and former subordinated credit facility contained certain financial and operational covenants, including restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the ability of the Company to pay dividends and make other distributions. The Company was in compliance with the financial and operational covenants of the former credit facility and former subordinated credit facility as of December 31, 2013.

In connection with the former senior credit facility and former subordinated credit facility, as well as other former credit facilities that were in place previously, the Company issued to the lenders warrants to purchase a total of: i) 592,501 shares of common stock at $0.015 per share, ii) 112,959 shares of Series F redeemable convertible preferred stock at $7.61 per share, and (iii) 110,018 shares of Series C redeemable convertible preferred stock at $3.27 per share. Each of the above warrants were immediately exercisable and, accordingly, the Company calculated the fair value of the warrants using the Black-Scholes option pricing model and recorded deferred financing costs related to the issuances of the warrants in the respective periods.

On April 2, 2014, in connection with the closing of the Company’s IPO, the above warrants to purchase 222,977 shares of preferred stock were converted into warrants to purchase an aggregate of 148,650 shares of common stock. This conversion resulted in the warrant liability of $1,140 being reclassified to additional paid-in capital as of April 2, 2014.

XML

Significant Accounting Policies (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013
Significant Accounting Policies (Details) [Line Items]
Proceeds from Issuance Initial Public Offering		$ 72,019
Payments for Underwriting Expense		8,325
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478
Common Stock, No Par Value		$ 14.00
Convertible Preferred Stock, Shares Issued upon Conversion		18,457,235
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686
Temporary Equity, Shares Issued		149,839
Class of Warrant or Right, Outstanding	100,000	222,977
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	149,839	148,650
Adjustment of Warrants Granted for Services		1,140
Debtor Reorganization Items, Write-off of Deferred Financing Costs and Debt Discounts		2,845
Banking Fees and Commissions		1,016
Capital Units, Adjustment for Market Changes		253
Number of Reportable Segments	1
Ratchet Provision Deemed Dividend [Member] | Series G Preferred Stock [Member]
Significant Accounting Policies (Details) [Line Items]
Dividends	$ 8,079	$ 8,079
Series G Preferred Stock [Member]
Significant Accounting Policies (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion		577,055
Minimum [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	five
Software and Software Development Costs [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three
Website And Mobile Applications [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three

XML

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

Definite-lived intangible assets consist of the following:

	December 31, 2013									March 31, 2014
	Gross carrying amount		Accumulated amortization			Net carrying amount		Weighted- average remaining useful life(1)		Gross carrying amount		Accumulated amortization			Net carrying amount		Weighted- average remaining useful life(1)
Customer relationships	$	11,910	$	(10,481	)	$	1,429		2.9	$	11,910	$	(10,624	)	$	1,286		2.7
Other intangibles		3,900		(2,925	)		975		1.7		3,900		(3,064	)		836		1.5
Trade names		10,505		(3,174	)		7,331		7.0		10,505		(3,437	)		7,068		6.7
Total	$	26,315	$	(16,580	)	$	9,735			$	26,315	$	(17,125	)	$	9,190

⁽¹⁾ The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Future amortization expense of the intangible assets is estimated to be as follows:

Year ending December 31:
2014 (April 1st to December 31st)	$	1,636
2015		1,938
2016		1,248
2017		1,239
2018		1,051
Thereafter		2,078
Total	$	9,190

XML

Income Taxes

3 Months Ended

Mar. 31, 2014

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

9. Income Taxes

The Company’s interim and annual tax provision is primarily comprised of a deferred tax provision pertaining to basis differences in indefinite lived intangible assets that cannot be offset by current year deferred tax assets, as well as, to a much lesser extent, a current tax provision for state, local and foreign taxes. Based on seasonality, the Company has historically experienced pretax losses in certain quarters and pretax income in others. Due to the combination of these items, the Company believes that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense and pretax income or loss in interim periods. As a result, the tax provision in interim periods is based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate.

At December 31, 2013, the Company had approximately $108,000 of NOL carryforwards available to offset future taxable income, which expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. The Company’s NOL carryforwards at December 31, 2013 include $3,317 in income tax deductions related to stock options. The benefit of these losses will be reflected as a credit to additional paid-in capital as realized.

The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realizable. In determining realizability, the Company considered various factors including historical profitability and reversing temporary differences. The Company’s net deferred tax liabilities arose due primarily to basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets.

The Company is subject to taxation in the U.S. and various state, local and foreign jurisdictions. In February 2014, the Company received notification that its U.S. Federal tax return for the year ended December 31, 2011 would be audited. As of March 31, 2014, none of the Company’s other tax returns have been examined by any income taxing authority. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

7. Stock-Based Compensation

Stock Options

The Company has historically granted non-statutory stock options to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”). The Board of Directors and the Company’s stockholders subsequently approved the 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional options have been or will be granted under the 2003 Plan.

The aggregate number of shares of the Company’s common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting). In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors. As of March 31, 2014, 593,574 shares have been reserved for issuance under the 2014 Plan and no shares have been granted under the 2014 Plan.

The following table summarizes stock option activity for the three months ended March 31, 2014:

	Number of options			Weighted- average exercise price		Weighted- average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at December 31, 2013		5,457,791		$	7.61		6.54		20,396
Granted		1,472,101			14.53
Exercised		(113,580	)		4.26
Cancelled		(142,506	)		8.22
Outstanding at March 31, 2014		6,673,806		$	9.14		7.12	$	33,737
Exercisable at March 31, 2014		3,965,974		$	7.33		5.59	$	26,396

Proceeds from the exercise of options and the total intrinsic value of the options exercised were $1,172 and $910, respectively, for the three months ended March 31, 2014. Proceeds from the exercise of options and the total intrinsic value of the options exercised were $3 and $12, respectively, for the three months ended March 31, 2013.

There were no options granted during the three months ended March 31, 2013. The weighted-average fair value per share at date of grant for options granted during the three months ended March 31, 2014 was $7.56. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method.

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2013 and 2014:

	2013		2014
Volatility	50.26	%	49.77	%
Expected life (years)	6.25		6.25
Risk-free interest rate	1.32	%	1.92	%
Dividend yield	—		—

The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date.

Total stock-based compensation expense was $480 (including $28 relating to discontinued operations) and $1,069 for the three months ended March 31, 2013 and 2014, respectively.

At March 31, 2014, there was approximately $11,755 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.98 years. The total fair value of stock options vested during the three months ended March 31, 2013 and 2014 was $1,402 and $953, respectively.

2014 Employee Stock Purchase Plan

The Company’s directors adopted, and the stockholders subsequently approved, the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP, which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. For the initial offering period, the fair market value on the first day of the offering period was the $14.00 IPO price. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee. The ESPP did not materially impact the Company’s results of operations for the three months ended March 31, 2014.

XML

Net Loss Per Share

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

8. Net Loss Per Share

Basic net loss per share is computed by dividing net loss by the weighted-average number of outstanding shares of common stock during the period. Diluted net loss per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential common shares outstanding during the period. Potential common shares include incremental shares issuable upon the assumed exercise of stock options and warrants using the treasury stock method. For the three months ended March 31, 2013 and 2014, the Company had outstanding options, warrants and preferred stock as disclosed in Notes 5, 6 and 7, which were convertible into or exercisable for common shares that were not included in the calculation of diluted loss per common share because the effect would have been anti-dilutive.

The unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 assumes as of the first day of the quarter then ended (i) the conversion of all outstanding shares of redeemable convertible preferred stock into an aggregate of 18,457,235 shares of common stock, (ii) the issuance of 149,839 shares of common stock upon the automatic net exercise of a warrant, (iii) the issuance and sale of 5,622,686 common shares, including 262,686 from exercises of stock options and warrants by selling stockholders, upon the closing of the IPO, and (iv) the issuance and sale of 316,414 common shares pursuant to the underwriters’ exercise of their over-allotment option. Additionally, the pro forma net loss per share attributable to common stockholders reflects a deemed dividend on Series G redeemable convertible preferred stock of $8,079 resulting from the Series G ratchet provision (refer to Note 6).

	Three months ended March 31, 2014
Numerator:
Historical net loss		$	(7,759	)
Plus: deemed dividend on Series G Preferred Stock			(8,079	)
Pro forma numerator for basic and diluted net loss per share attributable to common stockholders		$	(15,838	)
Denominator:
Historical denominator for basic and diluted net loss per share—weighted average shares			5,403,846
Plus: conversion of redeemable convertible preferred stock to common stock			18,457,235
Plus: automatic net exercise of a warrant			149,839
Plus: shares issued upon initial public offering, including shares exercised by certain selling shareholders			5,622,686
Plus: shares issued pursuant to the underwriters’ exercise of their over-allotment option			316,414
Pro forma denominator for basic and diluted net loss per share attributable to common shareholders			29,950,020
Pro forma basic and diluted net loss per share attributable to common shareholders		$	(0.53	)

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

10. Commitments and Contingencies

The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

XML

Net Loss Per Share (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013
Net Loss Per Share (Details) [Line Items]
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686
Pro Forma [Member] | Unaudited pro forma assumptions [Member]
Net Loss Per Share (Details) [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	18,457,235
Common Stock, Shares, Issued	149,839
Stock Issued During Period, Value, New Issues (in Dollars)	$ 5,622,686
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	262,686
Pro Forma [Member]
Net Loss Per Share (Details) [Line Items]
Common Stock, Shares, Issued	30,091,942
Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member] | Unaudited pro forma assumptions [Member]
Net Loss Per Share (Details) [Line Items]
Common Stock Shares Issued Upon Shoe Exercise	316,414
Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member]
Net Loss Per Share (Details) [Line Items]
Stock Issued During Period, Value, New Issues (in Dollars)	316,414
Unaudited pro forma assumptions [Member] | Ratchet Provision Deemed Dividend [Member]
Net Loss Per Share (Details) [Line Items]
Dividends (in Dollars)	$ 8,079,000

XML

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes stock option activity for the three months ended March 31, 2014:

	Number of options			Weighted- average exercise price		Weighted- average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at December 31, 2013		5,457,791		$	7.61		6.54		20,396
Granted		1,472,101			14.53
Exercised		(113,580	)		4.26
Cancelled		(142,506	)		8.22
Outstanding at March 31, 2014		6,673,806		$	9.14		7.12	$	33,737
Exercisable at March 31, 2014		3,965,974		$	7.33		5.59	$	26,396

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2013 and 2014:

	2013		2014
Volatility	50.26	%	49.77	%
Expected life (years)	6.25		6.25
Risk-free interest rate	1.32	%	1.92	%
Dividend yield	—		—

XML

Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014		Dec. 31, 2013
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]
Gross carrying amount	$ 26,315		$ 26,315
Accumulated amortization	(17,125)		(16,580)
Net carrying amount	9,190		9,735
Customer Relationships [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]
Gross carrying amount	11,910		11,910
Accumulated amortization	(10,624)		(10,481)
Net carrying amount	1,286		1,429
Weighted- average remaining useful life	2 years 255 days	[1]	2 years 328 days	[1]
Other Intangible Assets [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]
Gross carrying amount	3,900		3,900
Accumulated amortization	(3,064)		(2,925)
Net carrying amount	836		975
Weighted- average remaining useful life	1 year 6 months	[1]	1 year 255 days	[1]
Trade Names [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]
Gross carrying amount	10,505		10,505
Accumulated amortization	(3,437)		(3,174)
Net carrying amount	$ 7,068		$ 7,331
Weighted- average remaining useful life	6 years 255 days	[1]	7 years	[1]

[1] The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

XML

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit (USD $) In Thousands, except Share data	Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012	$ 158,766	$ 49		$ 26,759	$ (105,458)	$ (78,650)
Balance (in Shares) at Dec. 31, 2012	26,820,270	4,860,855
Exercise of stock options				3		3
Exercise of stock options (in Shares)		1,666
Issuance of common stock		1		980		981
Issuance of common stock (in Shares)		108,047
Purchase of treasury stock			(55)			(55)
Purchase of treasury stock (in Shares)		(7,900)
Stock-based compensation expense related to stock options				480		480
Net loss					(9,229)	(9,229)
Balance at Mar. 31, 2013	158,766	50	(55)	28,222	(114,687)	(86,470)
Balance (in Shares) at Mar. 31, 2013	26,820,270	4,962,668
Balance at Dec. 31, 2013	158,766	54	(55)	33,726	(123,694)	(89,969)
Balance (in Shares) at Dec. 31, 2013	26,820,270	5,366,478
Exercise of stock options		1		482		483
Exercise of stock options (in Shares)		113,580				113,580
Issuance of common stock		1		918		919
Issuance of common stock (in Shares)		65,710				5,545,768
Stock-based compensation expense related to stock options				1,069		1,069
Warrant issued in connection with website partner agreement				1,131		1,131
Net loss					(7,759)	(7,759)
Balance at Mar. 31, 2014	$ 158,766	$ 56	$ (55)	$ 37,326	$ (131,453)	$ (94,126)
Balance (in Shares) at Mar. 31, 2014	26,820,270	5,545,768

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

4. Goodwill and Other Intangible Assets

The carrying value of the Company’s goodwill was $82,153 as of March 31, 2014. Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable. Application of the impairment test requires judgment and results in impairment being recognized if the carrying value of the asset exceeds its fair value. No indicators of impairment were noted during or since the Company’s last evaluation of goodwill at October 1, 2013. Similarly, the Company’s definite-lived intangible assets with a net carrying value of $9,190 at March 31, 2014, consisting principally of trade names, customer relationships and agreements with certain of the Company’s website partners, is reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s definite-lived intangible assets during the three months ended 2013 and 2014.

Definite-lived intangible assets consist of the following:

	December 31, 2013									March 31, 2014
	Gross carrying amount		Accumulated amortization			Net carrying amount		Weighted- average remaining useful life(1)		Gross carrying amount		Accumulated amortization			Net carrying amount		Weighted- average remaining useful life(1)
Customer relationships	$	11,910	$	(10,481	)	$	1,429		2.9	$	11,910	$	(10,624	)	$	1,286		2.7
Other intangibles		3,900		(2,925	)		975		1.7		3,900		(3,064	)		836		1.5
Trade names		10,505		(3,174	)		7,331		7.0		10,505		(3,437	)		7,068		6.7
Total	$	26,315	$	(16,580	)	$	9,735			$	26,315	$	(17,125	)	$	9,190

⁽¹⁾ The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Amortization expense relating to the definite-lived intangible assets totaled $1,015 and $545 for the three months ended March 31, 2013 and 2014, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations.

Future amortization expense of the intangible assets is estimated to be as follows:

Year ending December 31:
2014 (April 1st to December 31st)	$	1,636
2015		1,938
2016		1,248
2017		1,239
2018		1,051
Thereafter		2,078
Total	$	9,190

XML

Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Schedule of future amortization expense of intangible assets [Abstract]
2014 (April 1st to December 31st)	$ 1,636
2015	1,938
2016	1,248
2017	1,239
2018	1,051
Thereafter	2,078
Total	$ 9,190	$ 9,735

XML

Common Stock and Redeemable Convertible Preferred Stock (Tables)

3 Months Ended

Mar. 31, 2014

Share-based Arrangements with Employees and Nonemployees [Abstract]

Redeemable Noncontrolling Interest [Table Text Block]

The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at each of December 31, 2013 and March 31, 2014:

	Shares				Stated value,
	Authorized		Issued and outstanding		net of expenses		Liquidation preference
Redeemable convertible preferred stock:
Series A		3,450,000		3,450,000	$	1,053	$	1,725
Series B		2,547,252		2,547,252		4,413		4,500
Series C		1,943,651		1,833,633		5,882		6,000
Series D		3,934,855		3,934,855		25,354		27,027
Series E		8,930,966		8,930,966		71,250		15,789
Series F		3,064,087		2,951,128		22,468		22,468
Series G		3,333,333		3,172,436		28,346		37,118
Total		27,204,144		26,820,270	$	158,766	$	114,627